Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

3 May 2021

Abstract excerpt

Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progressed substantially. The development of a rapid, accurate point-of-care test is essential for the prevention and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34063629
DOI: 10.3390/ijms22094842

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBVPMID 34063629Read ↗

Dual Detection of Hepatitis B and C Viruses Using CRISPR‐Cas Systems and Lateral Flow AssaySemantic proximity Read ↗

A CRISPR-Cas12b–Based Platform for Ultrasensitive, Rapid, and Highly Specific Detection of Hepatitis B Virus Genotypes B and C in Clinical ApplicationSemantic proximity Read ↗

CRISPR/Cas13a-Assisted accurate and portable hepatitis D virus RNA detectionSemantic proximity Read ↗

Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infectionSemantic proximity Read ↗

From Lab to Life: The Rise of CRISPR-Based Diagnostics for Point-of-Care and Global HealthSemantic proximity Read ↗

Nucleic Acid Detection Using CRISPR/Cas Biosensing TechnologiesSemantic proximity Read ↗

CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detectionSemantic proximity Read ↗

CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care DiagnosticsSemantic proximity Read ↗

Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12aSemantic proximity Read ↗

Bio-SCAN: A CRISPR/dCas9-Based Lateral Flow Assay for Rapid, Specific, and Sensitive Detection of SARS-CoV-2Semantic proximity Read ↗

Highly Specific and Rapid Detection of Hepatitis C Virus Using RT-LAMP-Coupled CRISPR–Cas12 AssaySemantic proximity Read ↗

Detection of Parasites in the Field: The Ever-Innovating CRISPR/Cas12aSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.